Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 9/20 | 0.40 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | THRA | P10827 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | MAP2 | P11137 | 2/20 | 0.36 |
| ▸ | FABP3 | P05413 | 1/20 | 0.35 |
| ▸ | FABP4 | P15090 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | MAT2A | P31153 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23813397 | 0.84 | ESR1 (0.44) | DPP4ESR1ESR2THRATHRB | |
| SCHEMBL29770955 | 0.84 | ESR1 (0.44) | DPP4ESR1ESR2THRATHRB | |
| SCHEMBL23263707 | 0.81 | ESR1 (0.49) | DPP4ESR1ESR2THRATHRB | |
| SCHEMBL23242751 | 0.81 | ESR1 (0.49) | DPP4ESR1ESR2THRATHRB | |
| SCHEMBL29770889 | 0.81 | ESR1 (0.49) | DPP4ESR1ESR2THRATHRB | |
| SCHEMBL574096 | 0.79 | ESR1 (0.53) | DPP4ESR1ESR2MAP2KDM4E | |
| SCHEMBL29416110 | 0.79 | ESR1 (0.53) | DPP4ESR1ESR2MAP2KDM4E | |
| SCHEMBL29770981 | 0.77 | DPP4 (0.45) | DPP4ESR1ESR2THRATHRB | |
| SCHEMBL23813405 | 0.77 | DPP4 (0.45) | DPP4ESR1ESR2THRATHRB | |
| SCHEMBL824215 | 0.76 | MEN1 (0.46) | DPP4ESR1ESR2MAP2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210284590-A1 | Anthracene Compound for Host Material, Light-Emitting Device, Light-Emitting Apparatus, Electronic Apparatus, and Lighting Apparatus | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210284590-A1 | Anthracene Compound for Host Material, Light-Emitting Device, Light-Emitting Apparatus, Electronic Apparatus, and Lighting Apparatus | CRY1, GNA11, GMNN | DPP4 4864/4885ESR1 169/4885ESR2 1300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.